CompletedNot Applicable

Effect of Endoscopic Papillary Balloon Dilation on ERCP Complications

China1,920 participantsStarted 2016-02

Plain-language summary

The purpose of this study is to determine how different endoscopic papillary balloon dilatation (EPBD) duration time affects the complications after endoscopic retrograde cholangiopancreatography (ERCP) in the treatment of common bile duct stones.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age≥18 years * CBD stone patients, stone diameter≤1.5cm, CBD diameter≤2cm Exclusion Criteria: * Unwillingness or inability to consent for the study * Coagulation dysfunction (INR\> 1.3) and low peripheral blood platelet count (\<50×109 / L) or using anti-coagulation drugs * Previous EST or EPBD * Prior surgery of Bismuth Ⅱ and Roux-en-Y * Benign or malignant CBD stricture * Preoperative coexistent diseases: acute pancreatitis, GI tract hemorrhage, severe liver disease, primary sclerosing cholangitis (PSC), septic shock * Combined with Mirizzi syndrome and intrahepatic bile duct stones * Malignant disease * Biliary-duodenal fistula confirmed during ERCP * Pregnant women

What they're measuring

Post-ERCP pancreatitis

Timeframe: Within 7 days after ERCP

Trial details

NCT IDNCT02510495

SponsorHepatopancreatobiliary Surgery Institute of Gansu Province

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-11-01

View on ClinicalTrials.gov More Complications trials